PREDICTION OF DRUG DISPOSITION BY HUMAN DRUG METABOLIZING ENZYMES

通过人体药物代谢酶预测药物分布

基本信息

  • 批准号:
    11557191
  • 负责人:
  • 金额:
    $ 3.01万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

Drug oxidation activities of twelve recombinant human cytochrome P450 (P450) coexpressed with human NADPH-P450 reductase (NPR) in bacterial membranes (P450/NPR membranes) were determined and compared with those of other recombinant systems and of human liver microsomes. Addition of exogenous membrane-bound NPR to the P450/NPR membranes enhanced the catalytic activities of CYP2C8, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 ; however, enhancement of activities of CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2B6, CYP2D6, and CYP2E1 in membranes was not observed after the addition of NPR in 4-molar excess to each P450. Exogenous purified human cytochrome b_5 (b_5) further enhanced catalytic activities of CYP2A6, CYP2B6, CYP2C8, CYP2E1, CYP3A4, and CYP3A5/NPR membranes. Catalytic activities of CYP2C9 and CYP2C19 were enhanced by addition of b_5 in reconstitution systems but not in the P450/NPR membranes. Apo b_5 (devoid of heme) enhanced catalytic activities when added to the both systems, except for CYP2E1/NPR membranes and the reconstituted systems containing purified CYP2C8 or CYP2E1 in comparison with b_5. Catalytic activities in P450/NPR membranes plus b_5 systems were roughly similar to those measured with microsomes of insect cells coexpressing P450 with NPR (and b_5) and/or of human liver microsomes, based on equivalent P450 contents. These results suggest that interactions of P450 and NPR coexpressed in membranes and reconstituted systems appear to be different in some human CYP2 family enzymes, possibly due to a conformational role of b_5. P450/NPR membrane systems containing b_5 are useful models for prediction of the rates for liver microsomal P450-dependent drug oxidations.
在细菌膜中与人NADPH-P450还原酶(NPR)共表达的十二种重组人细胞色素P450(P450)的药物氧化活性(P450/NPR膜)与其他重组系统和人肝微粒体的药物氧化活性进行了比较。在P450/NPR膜中添加外源性膜结合的NPR增强了CYP2C8,CYP2C9,CYP2C19,CYP3A4和CYP3A5的催化活性;然而,在膜中未观察到膜中CYP1A1,CYP1A2,CYP1B1,CYP2A6,CYP2A6,CYP2B6,CYP2D6和CYP2E1的活性的增强,在向每个P450中添加NPR后,在4个摩尔过量中添加NPR后,未观察到膜中的CYP2E1。外源纯化的人细胞色素B_5(B_5)进一步增强了CYP2A6,CYP2B6,CYP2C8,CYP2E1,CYP3A4和CYP3A5/NPR膜的催化活性。 CYP2C9和CYP2C19的催化活性通过在重构系统中添加B_5增强,而不是在P450/NPR膜中增强。除了CYP2E1/NPR膜和包含纯化的CYP2C8或CYP2E1的重构系统外,APO B_5(缺乏血红素)将增强催化活性。 P450/NPR膜和B_5系统中的催化活性大致与用基于等效P450含量的NPR(和B_5)和/或人类肝微粒体共表达P450的昆虫细胞测量的催化活性大致相似。这些结果表明,在某些人CYP2家族酶中,P450和NPR在膜和重建系统中共表达的相互作用似乎是不同的,这可能是由于B_5的构象作用。含有B_5的P450/NPR膜系统是预测肝微粒体P450依赖性药物氧化速率的有用模型。

项目成果

期刊论文数量(48)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakajima M,et al.: "Azelastine N-demethylation by CYP3A4, CYP2D6, and CYP1A2 in human liver microsomes: Evaluation of approach to predict the contribution of multiple cytochrome P450s"Drug Metab Dispos. 27. 1381-1391 (1999)
Nakajima M 等人:“人肝微粒体中 CYP3A4、CYP2D6 和 CYP1A2 导致的氮卓斯汀 N-去甲基化:预测多种细胞色素 P450 贡献的方法评估”Drug Metab Dispos。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamazaki H,et al.: "Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P450 2C8 and P450 3A4 in human liver microsomes"Drug Metab Dispos. 27. 1260-1266 (1999)
Yamazaki H 等人:“人肝微粒体中细胞色素 P450 2C8 和 P450 3A4 催化曲格列酮氧化为醌型代谢物”Drug Metab Dispos。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMAZAKI Hiroshi其他文献

YAMAZAKI Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMAZAKI Hiroshi', 18)}}的其他基金

Relevance to bioactivation and toxicity of thalidomide, pomalidomide, and lenalidomide by human cytochrome P450 3A enzymes in cultured placental cells and humanized-liver mice
培养胎盘细胞和人源化肝小鼠中人细胞色素 P450 3A 酶与沙利度胺、泊马度胺和来那度胺生物活性和毒性的相关性
  • 批准号:
    17K08425
  • 财政年份:
    2017
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of resistance to molecularly targeted drugs for oral squamous cell carcinoma and investigation of countermeasures
口腔鳞癌分子靶向药物耐药机制及对策研究
  • 批准号:
    16K11732
  • 财政年份:
    2016
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Effective Markers for Resistance of Oral Squamous Cell Carcinoma to Molecular-targeting Drugs
口腔鳞状细胞癌分子靶向药物耐药性有效标志物的开发
  • 批准号:
    25463120
  • 财政年份:
    2013
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Thalidomide increases cytochrome P450 activity and drug metabolism in liver through direct activation of nuclear receptor CAR and PXR
沙利度胺通过直接激活核受体 CAR 和 PXR 增加肝脏细胞色素 P450 活性和药物代谢
  • 批准号:
    23590200
  • 财政年份:
    2011
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
evaluationofeffectivenessoftheobjectiveexaminationforautism indeafchildren
聋儿自闭症客观检查效果评价
  • 批准号:
    22791642
  • 财政年份:
    2010
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Role of cancer stem cells related molecules in oral squamous cell carcinoma
肿瘤干细胞相关分子在口腔鳞癌中的作用
  • 批准号:
    22592246
  • 财政年份:
    2010
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanism of chemical-induced toxicity in fetal livers
化学品致胎儿肝脏毒性的分子机制
  • 批准号:
    17390034
  • 财政年份:
    2005
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular Mechanisms of Toxic Expression Induced by Endocrine Disruptors via AHR
内分泌干​​扰物通过 AHR 诱导毒性表达的分子机制
  • 批准号:
    15390040
  • 财政年份:
    2003
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study on the separation of rac and meso isomers and the reactivity of group 4 bridged metallocene complexes
外消旋和内消旋异构体的分离及第4族桥联茂金属配合物的反应性研究
  • 批准号:
    11640544
  • 财政年份:
    1999
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creation of Substitution Labile Pyrazolylborate Metal Complexes
取代不稳定的吡唑基硼酸盐金属配合物的制备
  • 批准号:
    09640675
  • 财政年份:
    1997
  • 资助金额:
    $ 3.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

人肝微粒体CYP代谢药物个体差异技术平台的建立及关键基础研究
  • 批准号:
    81473279
  • 批准年份:
    2014
  • 资助金额:
    70.0 万元
  • 项目类别:
    面上项目

相似海外基金

Inter-Enzyme Crosstalk in the Cytochrome P450 Ensemble: Implications for the Effects of Alcohol on Drug Metabolism and Alcohol-Drug Interactions
细胞色素 P450 整体中的酶间串扰:酒精对药物代谢和酒精-药物相互作用影响的影响
  • 批准号:
    10704053
  • 财政年份:
    2022
  • 资助金额:
    $ 3.01万
  • 项目类别:
Computationally modeling the impact of ontogeny on drug metabolic fate
计算模拟个体发育对药物代谢命运的影响
  • 批准号:
    9215358
  • 财政年份:
    2016
  • 资助金额:
    $ 3.01万
  • 项目类别:
Computationally modeling the impact of ontogeny on drug metabolic fate
计算模拟个体发育对药物代谢命运的影响
  • 批准号:
    9762980
  • 财政年份:
    2016
  • 资助金额:
    $ 3.01万
  • 项目类别:
Pharmacogenetics and Drug Interactions
药物遗传学和药物相互作用
  • 批准号:
    7267686
  • 财政年份:
    2004
  • 资助金额:
    $ 3.01万
  • 项目类别:
PREDICTION OF DRUG INTERACTIONS IN VIVO AND IN VITRO
体内和体外药物相互作用的预测
  • 批准号:
    6240431
  • 财政年份:
    1997
  • 资助金额:
    $ 3.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了